Institutional Resources
Supporting psychedelic research from development to testing to implementation
Duke Clinical Research Institute
As part of the University School of Medicine, the Duke Clinical Research Institute (DCRI) is the world’s largest academic clinical research organization. Trial services provided by the DCRI include: early phase clinical research (phase I), phase II/III development, mega-trials (> 5,000 patients), device trials, and post-marketing surveillance/late-phase trials. The DCRI offers full-service capabilities at every stage of clinical development, from study design and regulatory strategy to participant recruitment and safety surveillance to data management and more. With more than 750 operational employees, the DCRI also manages trial communication, coordination, and engagement. To learn more about these services, click here.
Duke Early Phase Research Unit
As part of the Office of Clinical Research, the Duke Early Phase Research Unit (DEPRU) partners with academic institutions, pharmaceutical and biotechnology companies, government agencies, and non-profit organizations to conduct a variety of studies, from proof-of-concept to first-in-human trials. The DEPRU provides full service capabilities, including state-of-the-art technologies; specialized facilities equipped with inpatient and outpatient units as well as 24/7 medical staff coverage; adaptive study design; rapid participant recruitment; specimen collection, processing, and storage; and data integration and analytics. To learn more about these services, click here.
Investigational Drug Services
Located in the Department of Pharmacy at Duke University Health System, the Investigational Drug Services supports clinical research involving study drugs for Duke Investigators; and supports the safety and care for subjects in both the inpatient and outpatient care areas. The Investigational Drug Services integrates its activities with the clinical, safety, informatics, administrative, and drug distribution systems of the department, in effort to optimize study drug therapy for participants. To learn more about these services, click here.
Brain Imaging & Analysis Center
As part of the Duke University Medical Center, the Brain Imaging and Analysis Center (BIAC) supports research techniques in neuroimaging and their incorporation into basic and translational neuroscience. As such, the BIAC comprises three research groups in Imaging and Analysis Methodology, Translational Neuroimaging, and Cognitive Neuroimaging. The center also houses two research-dedicated whole-body 3T human scanners (both operating on the newest GE MR750 platforms); and its computing facilities consist of a high-speed network of Windows and Linux servers, workstations, and cluster nodes. To learn more about these services, click here.